Why AbbVie Could Join the M&A Mania Soon Post author:Sam Post published:January 30, 2018 Post category:BioPharma The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash. Source: BioSpace You Might Also Like Zika Testing Mistakes Require Re-testing Of Over 400 Specimens February 16, 2017 How High Novo Nordisk Could and Should Go for Ablynx January 23, 2018 Why Bluebird Bio Investors Aren't Singing the Blues December 12, 2017